《業績》卡夫亨氏(KHC.US)次季錄93億美元減值撥備 仍考慮分拆或出售方案
卡夫亨氏(KHC.US)公布,第二季虧損79.7億美元,每股虧損6.6美元,調整後每股盈利69美仙,高於預期的64美仙。營收下降1.9%至63.5億美元,但高於華爾街預期的62.7億美元。去年同期盈利1億美元,每股盈利8美仙。
卡夫亨氏次季錄得93億美元非現金減值撥備,主要是股價和市值持續下滑。
公司重申正考慮是否分拆或採取其他重大行動以釋放價值,目前尚無做出決定的時間表,因為公司正積極推進對各種選項的嚴格審查。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.